Evidence map›Paper›PMID 34069796›Full record

ArticlePathogens (Basel, Switzerland)2021

An Outer Membrane Vesicle-Adjuvanted Oral Vaccine Protects Against Lethal, Oral

Jaikin E Harrell, Jonathan R Kurtz, David L Bauer, J Timothy Prior, Patrick S Gellings, Lisa A Morici, James B McLachlan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathogens (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Adjuvants forVirulence · 2024
    Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jaikin E HarrellDepartment of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA 70112, USA.ORCID 0000-0002-2194-3978
Jonathan R KurtzDepartment of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
David L BauerDepartment of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
J Timothy PriorDepartment of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Patrick S GellingsDepartment of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Lisa A MoriciDepartment of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA 70112, USA.ORCID 0000-0002-4799-4941
James B McLachlanDepartment of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA 70112, USA.

Funding

Using combination adjuvants to direct and control immune responses at the intestinal mucosaU01AI124289 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI MCLACHLAN, JAMES B · 2016 to 2020
$2.4M
National Institute of Allergy and Infectious Diseases U01AI124289
6 · The paper itself

Abstract

Non-typhoidal salmonellosis, caused by

Indexed as

mucosal immunityouter membrane vesiclesSalmonellavaccine

Identifiers

PMID34069796
PMCPMC8157261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.